检索结果 - Francesca Cottini
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
-
5
General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL 由 Claudia Fazi, Lydia Scarfò, Lorenza Pecciarini, Francesca Cottini, Antonis Dagklis, Agnieszka Januś, Anna Maria Talarico, Cristina Scielzo, Cinzia Sala, Daniela Toniolo, Federico Caligaris‐Cappio, Paolo Ghia
出版 2011Artigo -
6
Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma 由 Ehsan Malek, M A Y Abdel-Malek, Sajjeev Jagannathan, Nikhil Vad, Rebekah Karns, Anil G. Jegga, Annemiek Broyl, Mark van Duin, Pieter Sonneveld, Francesca Cottini, Kenneth C. Anderson, James J. Driscoll
出版 2016Artigo -
7
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs 由 Diana Cirstea, Teru Hideshima, Loredana Santo, Homare Eda, Yuji Mishima, Neeharika Nemani, Yiguo Hu, Naoya Mimura, Francesca Cottini, Güllü Görgün, Hiroto Ohguchi, Rikio Suzuki, Hannes Loferer, Nikhil C. Munshi, K. C. Anderson, Noopur Raje
出版 2013Artigo -
8
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma 由 J. Minami, Rikio Suzuki, Ralph Mazitschek, Güllü Görgün, Balaram Ghosh, Diana Cirstea, Yiguo Hu, Naoya Mimura, Hiroto Ohguchi, Francesca Cottini, Jana Jakubı́ková, Nikhil C. Munshi, Stephen J. Haggarty, Paul G. Richardson, Teru Hideshima, Kristina Anderson
出版 2013Artigo -
9
p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma 由 Teru Hideshima, Francesca Cottini, Yoshihisa Nozawa, Hyuk‐Soo Seo, Hiroto Ohguchi, Mehmet Samur, Diana Cirstea, Naoya Mimura, Yoshikazu Iwasawa, Paul G. Richardson, Nikhil C. Munshi, Dharminder Chauhan, Walter Massefski, Teruhiro Utsugi, Sirano Dhe‐Paganon, Kenneth C. Anderson
出版 2017Artigo -
10
Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition 由 Naoya Mimura, Teru Hideshima, Toshiyasu Shimomura, Rikio Suzuki, Hiroto Ohguchi, Ola Rizq, Shohei Kikuchi, Yasuhiro Yoshida, Francesca Cottini, Jana Jakubı́ková, Diana Cirstea, Güllü Görgün, Jiro Minami, Yu‐Tzu Tai, Paul G. Richardson, Teruhiro Utsugi, Atsushi Iwama, Kenneth C. Anderson
出版 2014Artigo -
11
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition 由 Michele Cea, Antonia Cagnetta, Mariateresa Fulciniti, Yu‐Tzu Tai, Teru Hideshima, Dharminder Chauhan, Aldo M. Roccaro, Antonio Sacco, Teresa Calimeri, Francesca Cottini, Jana Jakubı́ková, Sun‐Young Kong, Franco Patrone, Alessio Nencioni, Marco Gobbi, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson
出版 2012Artigo -
12
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma 由 Teru Hideshima, Jun Qi, Ronald M. Paranal, Weiping Tang, Edward F. Greenberg, Nathan West, Meaghan Colling, Guillermina Estiú, Ralph Mazitschek, Jennifer A. Perry, Hiroto Ohguchi, Francesca Cottini, Naoya Mimura, Güllü Görgün, Yu‐Tzu Tai, Paul G. Richardson, Ruben D. Carrasco, Olaf Wiest, Stuart L. Schreiber, Kenneth C. Anderson, James E. Bradner
出版 2016Artigo -
13
Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers 由 Francesca Cottini, Teru Hideshima, Chunxiao Xu, Martin Sattler, Martina Dori, Luca Agnelli, Elisa ten Hacken, Maria Teresa Sabrina Bertilaccio, Elena Antonini, Antonino Neri, Maurilio Ponzoni, Magda Marcatti, Paul G. Richardson, Ruben D. Carrasco, Alec C. Kimmelman, Kwok‐Kin Wong, Federico Caligaris‐Cappio, Giovanni Blandino, W. Michael Kuehl, Kenneth C. Anderson, Giovanni Tonon
出版 2014Artigo
相关主题
Biology
Cancer research
Biochemistry
Apoptosis
Immunology
Multiple myeloma
Medicine
Cell biology
Gene
Genetics
Bortezomib
Chemistry
Internal medicine
Pharmacology
Cytotoxicity
DNA
In vitro
Proteasome inhibitor
Antibody
CD5
Cancer
Chronic lymphocytic leukemia
DNA damage
DNA repair
Downregulation and upregulation
Environmental health
Gene knockdown
Genome instability
Histone
Histone deacetylase